Public Investors Valuations Earnings Pricing

Investors Valuations Earnings Pricing Workspace

KalVista Pharmaceuticals, Inc.

KALV

HealthcareBiotechnologyNASDAQ

$26.80

Market Cap: $1.37B

Valuation Financials Forecast Compare Historical Price Solvency Dividends Transactions People

Transactions

This section is coming soon.

SweetValueLab

Find the sweet spot to buy. 9 valuation models, updated daily.

Product

Valuations
Earnings Calendar
Watchlist
FI Calculator
Methodology
Pricing
About

Popular Stocks

AAPL Valuation
NVDA Valuation
MSFT Valuation
GOOGL Valuation
AMZN Valuation
INTC Valuation
RKLB Valuation

Valuation Models

DCF Growth Exit
DCF EBITDA Exit
P/E Multiples
EV/EBITDA Multiples
PEG Ratio

© 2026 Sweet Value Lab. All rights reserved.

Not financial advice. Data may be delayed.